DNM2 and centronuclear myopathy: Considering recessive CNM cases with non-progressive muscle involvement, homozygous missense mutations in the BAR domain impair the membrane tubulation properties, and premature truncation of the SH3 domain reduces the binding to dynamin 2 (DNM2) (Nicot et al., 2007).